Occupational Superannuation Standards Regulations (Amendment) (Cth)
I, THE
GOVERNOR-GENERAL of the Commonwealth of Australia, acting with the advice of
the Federal Executive Council, make the following Regulations under the
Dated 21 April 1992.
BILL HAYDEN
Governor-General
By His Excellency’s Command,
PETER COOK
Minister of State for Industrial Relations
for and on behalf of the
Minister of State for Aged, Family
and Health Services
____________
1.1 The Therapeutic Goods Regulations are amended as set out in these Regulations.
These
Regulations commence on gazettal: see
s. 48]
2.1 Subregulation 16C (1):
Add at the end:
“; and
is not an application to which subregulation 16G applies.”.
2.2 Subregulation 16C (2):
Omit all the words from and including “the later” to the end of the subregulation, substitute “the day on which the Secretary sends a notification to the applicant under regulation 16B that indicates acceptance of the application in relation to the evaluation.”.
2.3 Paragraph 16C (4) (a):
Omit all the words from and including “marketing” to the end of the paragraph, substitute “marketing;”.
2.4 Subparagraph 16C (5) (b) (iii):
After “another report”, insert “(being an evaluation report)”.
2.5 Subregulation 16C (6) (definition of “acceptable country”):
Omit
“
3.1 Subregulation 16D (2):
Omit all the words from and including “the later” to the end of the subregulation, substitute “the day on which the Secretary sends a notification to the applicant under regulation 16B that indicates acceptance of the application.”.
3.2 Paragraph 16D (4) (a):
Omit all the words from and including “marketing” to the end of the paragraph, substitute “marketing;”.
3.3 Subparagraph 16D (5) (b) (iii):
After “another report”, insert “(being an evaluation report)”.
4.1 After regulation 16F, insert in Part 3A:
“
(a) the application is received by the Secretary on or after 1 July 1992; and
(b) the application requires an evaluation under section 25 of the Act; and
(c) the sponsor of the application holds a registration for a drug that contains the same active ingredient or active ingredients, in the same dosage form and strength as stated in the application.
This regulation does not apply to an application that, in the opinion of the Secretary, needs to be supported by clinical, pre-clinical or bio-equivalence data.
The provisions of subregulations 16F (3), (4) and (5) apply to applications to which this regulation applies as if those applications were applications to which regulation 16F applies.”.
1. Notified in the
2. Statutory Rules 1990 No. 394 as amended by 1991 Nos. 84 and 485; 1992 Nos. 19 and 89.
0
0
0